Simplex Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Simplex Trading’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$2K	–	10095
2023 Q3	$2K	Buy	4 +3	+300%	+$12.9K	﹤0.01%	8197
2023 Q2	$2K	Hold	1	–	–	﹤0.01%	8521
2023 Q1	$2K	Sell	1 -16	-94%	-$46.8K	﹤0.01%	8573
2022 Q4	$45K	Sell	17 -3	-15%	-$10.5K	﹤0.01%	6022
2022 Q3	$77K	Buy	20 +19	+1,900%	+$74.7K	﹤0.01%	5878
2022 Q2	$1K	Buy	+1	New	+$2.6K	﹤0.01%	9725
2022 Q1	–	Sell	-1	Closed	-$9K	–	11617
2021 Q4	$9K	Sell	1 -7	-88%	-$53.7K	﹤0.01%	9152
2021 Q3	$92K	Hold	8	–	–	﹤0.01%	6743
2021 Q2	$85K	Buy	+8	New	+$131K	﹤0.01%	6970
2021 Q1	–	Hold	0	–	–	–	4511
2015 Q1	–	Hold	0	–	-$1K	–	5740
2014 Q4	–	Hold	0	–	–	–	4337

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return

GJL

Gendell Jeffrey L $9.6B AUM 75.6% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Modera Wealth Management Westwood, New Jersey $9.5B AUM 16% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Simplex Trading's SEEL Position: Q2 2022 in Review

Simplex Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2022, closing a stake of 64 shares — an estimated $167K sold.

Simplex Trading first reported a position in SEEL in Q1 2021 and held it in 5 quarters. The position peaked at $315K in Q4 2021. 65 funds tracked by Wall St. Rank hold SEEL as of Q2 2022.

Simplex Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Simplex Trading sold 64 Seelos Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $167K.
Simplex Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Simplex Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $315K in Q4 2021.
65 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.